Cancer Cachexia: Identification by Clinical Assessment versus International Consensus Criteria in Patients with Metastatic Colorectal Cancer

References

• Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, et al.: Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12, 489–495, 2011.
   PubMed Web of Science ®Google Scholar
• Vigano A, Del Fabbro E, Bruera E, and Borod M: The cachexia clinic: from staging to managing nutritional and functional problems in advanced cancer patients. Crit Rev Oncog 17, 293–303, 2012.
   PubMedGoogle Scholar
• Thoresen L, Frykholm G, Lydersen S, Ulveland H, Baracos V, et al.: The association of nutritional assessment criteria with health-related quality of life in patients with advanced colorectal carcinoma. Eur J Cancer Care (Engl) 21, 505–516, 2012.
   PubMed Web of Science ®Google Scholar
• Thoresen L, Frykholm G, Lydersen S, Ulveland H, Baracos V, et al.: Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results. Clin Nutr 32, 65–72, 2013.
   PubMed Web of Science ®Google Scholar
• Bachmann J, Heiligensetzer M, Krakowski-Roosen H, Buchler MW, Friess H, et al.: Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg 12, 1193–1201, 2008.
   PubMed Web of Science ®Google Scholar
• Blum D, Stene GB, Solheim TS, Fayers P, Hjermstad MJ, et al.: Validation of the Consensus-Definition for Cancer Cachexia and evaluation of a classification model – a study based on data from an international multicentre project (EPCRC-CSA). Ann Oncol 25, 1635–1642, 2014.
   PubMed Web of Science ®Google Scholar
• Barret M, Antoun S, Dalban C, Malka D, Mansourbakht T, et al.: Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer. Nutr Cancer 66, 583–589, 2014.
   PubMed Web of Science ®Google Scholar
• Barret M, Malka D, Aparicio T, Dalban C, Locher C, et al.: Nutritional status affects treatment tolerability and survival in metastatic colorectal cancer patients: results of an AGEO prospective multicenter study. Oncology 81, 395–402, 2011.
   PubMed Web of Science ®Google Scholar
• Prado CM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, et al.: Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 15, 2920–2926, 2009.
   PubMed Web of Science ®Google Scholar
• Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, et al.: Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31, 1539–1547, 2013.
   PubMed Web of Science ®Google Scholar
• Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, et al.: Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9, 629–635, 2008.
   PubMed Web of Science ®Google Scholar
• Dunne RF, Mustian KM, Garcia JM, Dale W, Hayward R, et al.: Research priorities in cancer cachexia: The University of Rochester Cancer Center NCI Community Oncology Research Program Research Base Symposium on Cancer Cachexia and Sarcopenia. Curr Opin Support Palliat Care 11, 278–286, 2017.
   PubMed Web of Science ®Google Scholar
• Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, et al.: (Cachexia: a new definition. Clin Nutr 27. 793–799, 2008.
   PubMed Web of Science ®Google Scholar
• Wallengren O, Lundholm K, and Bosaeus I: Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients. Support Care Cancer 21, 1569–1577, 2013.
   PubMed Web of Science ®Google Scholar
• Muscaritoli M, Anker SD, Argiles J, Aversa Z, Bauer JM, et al.: Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 29, 154–159, 2010.
   PubMed Web of Science ®Google Scholar
• Del Fabbro E, Jatoi A, Davis M, Fearon K, di Tomasso J, et al.: Health professionals' attitudes toward the detection and management of cancer-related anorexia-cachexia syndrome, and a proposal for standardized assessment. J Community Support Oncol 13, 181–187, 2015.
   PubMedGoogle Scholar
• Muscaritoli M, Rossi Fanelli F, and Molfino A: Perspectives of health care professionals on cancer cachexia: results from three global surveys. Ann Oncol 27, 2230–2236, 2016.
   PubMed Web of Science ®Google Scholar
• Churm D, Andrew IM, Holden K, Hildreth AJ, and Hawkins C: A questionnaire study of the approach to the anorexia-cachexia syndrome in patients with cancer by staff in a district general hospital. Support Care Cancer 17, 503–507, 2009.
   PubMed Web of Science ®Google Scholar
• van der Werf A, Blauwhoff-Buskermolen S, Langius JA, Berkhof J, Verheul HM, et al.: The effect of individualized nutritional counseling on muscle mass and treatment outcome in patients with metastatic colorectal cancer undergoing chemotherapy: a randomized controlled trial protocol. BMC Cancer 15, 98, 2015.
   PubMed Web of Science ®Google Scholar
• Frank E, and Dunlop AL: What does a patient's outfit weight? Fam Med 32, 595–596, 2000.
   PubMed Web of Science ®Google Scholar
• Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, et al.: A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 33, 997–1006, 2008.
   PubMed Web of Science ®Google Scholar
• Shen W, Punyanitya M, Wang Z, Gallagher D, St-Onge MP, et al.: Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol (1985) 97, 2333–2338, 2004.
   PubMed Web of Science ®Google Scholar
• Wampler GL and Fryer JG: Calculation of received dose intensity for combinations of drugs using small-cell lung carcinoma treatment regimens as examples. Cancer Chemother Pharmacol 30, 199–206, 1992.
   PubMed Web of Science ®Google Scholar
• Nakayama G, Tanaka C, Uehara K, Mashita N, Hayashi N, et al.: The impact of dose/time modification in irinotecan- and oxaliplatin-based chemotherapies on outcomes in metastatic colorectal cancer. Cancer Chemother Pharmacol 73, 847–855, 2014.
   PubMed Web of Science ®Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, et al.: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45, 228–247, 2009.
   PubMed Web of Science ®Google Scholar
• Dancey JE, Dodd LE, Ford R, Kaplan R, Mooney M, et al.: Recommendations for the assessment of progression in randomised cancer treatment trials. Eur J Cancer 45, 281–289, 2009.
   PubMed Web of Science ®Google Scholar
• Landis JR and Koch GG: The measurement of observer agreement for categorical data. Biometrics 33, 159–174, 1977.
   PubMed Web of Science ®Google Scholar
• Wesseltoft-Rao N, Hjermstad MJ, Ikdahl T, Dajani O, Ulven SM, et al.: Comparing two classifications of cancer cachexia and their association with survival in patients with unresected pancreatic cancer. Nutr Cancer 67, 472–480, 2015.
   PubMed Web of Science ®Google Scholar
• Vanhoutte G, van de Wiel M, Wouters K, Sels M, Bartolomeeussen L, et al.: Cachexia in cancer: what is in the definition? BMJ Open Gastroenterol 3, e000097, 2016.
   PubMed Web of Science ®Google Scholar
• Fearon K, Arends J, and Baracos V: Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol 10, 90–99, 2013.
   PubMed Web of Science ®Google Scholar
• Andreyev HJ, Norman AR, Oates J, and Cunningham D: Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34, 503–509, 1998.
   PubMed Web of Science ®Google Scholar
• Sun L, Quan XQ, and Yu S: An epidemiological survey of cachexia in advanced cancer patients and analysis on its diagnostic and treatment status. Nutr Cancer 67, 1056–1062, 2015.
   PubMed Web of Science ®Google Scholar
• van der Werf A, Langius JAE, de van der Schueren MAE, Nurmohamed SA, van der Pant KAMI, et al.: Percentiles for skeletal muscle index, -area and -radiation attenuation based on computed tomography imaging in a healthy Caucasian population. Eur J Clin Nutr (Accepted 05 Oct 2017).
   Web of Science ®Google Scholar